StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > DO YOU THINK we can ever Reach 30 dollars per share

<< Previous

Bullboard Posts

Next >>

Comment by Northerencentson Mar 22, 2021 6:49pm

235 Views

Post# 32855329

RE:RE:RE:RE:RE:DO YOU THINK we can ever Reach 30 dollars per share

On a serious note just on fundamental changes to the company in the last year based on revenue increase and the trajectory it's on this should already be valued at 5 a share with out Aristotle once again just my opinion

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale